Pages that link to "Q72222110"
Jump to navigation
Jump to search
The following pages link to Monoamine neurons in aging and Alzheimer's disease (Q72222110):
Displaying 50 items.
- Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice (Q30542135) (← links)
- Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7-dihydroxytryptamine (Q31949032) (← links)
- Managing antipsychotic-induced parkinsonism (Q33604541) (← links)
- Altered pupillary size and darkness and light reflexes in Alzheimer's disease (Q33735928) (← links)
- Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease (Q33751924) (← links)
- Effects of Lifelong Ethanol Consumption on Brain Monoamine Transmitters in Alcohol-Preferring Alko Alcohol (AA) Rats (Q33772132) (← links)
- Mosaic aging (Q33790191) (← links)
- Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies (Q34077418) (← links)
- Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders (Q34108192) (← links)
- Ammonia and Alzheimer's disease (Q34646469) (← links)
- The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review (Q34951934) (← links)
- Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis (Q35018088) (← links)
- Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease (Q35179010) (← links)
- Brain aging research at the close of the 20th century: from bench to bedside (Q35236407) (← links)
- Tackling sleeplessness: psychological treatment options for insomnia in older adults (Q35740696) (← links)
- Sleep disturbances in Alzheimer's and Parkinson's diseases (Q35981780) (← links)
- Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice (Q36161613) (← links)
- A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders (Q36739665) (← links)
- Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice (Q36759431) (← links)
- A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease (Q36768052) (← links)
- The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease (Q36822309) (← links)
- Development of amyloid burden in African Green monkeys (Q36997081) (← links)
- Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease (Q37005143) (← links)
- Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease (Q37092481) (← links)
- Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps (Q37326505) (← links)
- A dual-hit animal model for age-related parkinsonism (Q37620482) (← links)
- Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons (Q38905310) (← links)
- Alzheimer's disease: fundamental and therapeutic aspects (Q40603923) (← links)
- Effects of age and GDNF on noradrenergic innervation of the hippocampal formation: studies from intraocular grafts (Q40784885) (← links)
- An Ammonia Hypothesis of Alzheimer Disease (Q41586852) (← links)
- Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease (Q41611032) (← links)
- Role of homocysteine in age-related vascular and non-vascular diseases (Q41634846) (← links)
- Fatty acids and brain peptides. (Q41717107) (← links)
- New atypical antipsychotics. Experience and utility in the elderly (Q41724199) (← links)
- Theta bursts in the olfactory nerve paired with beta-adrenoceptor activation induce calcium elevation in mitral cells: a mechanism for odor preference learning in the neonate rat. (Q41831296) (← links)
- Immunocytochemical study of catecholaminergic neurons in the senescence-accelerated mouse (SAM-P8) brain (Q42452202) (← links)
- Immunohistochemical and neurochemical correlates of learning deficits in aged rats (Q42483907) (← links)
- Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study (Q43758867) (← links)
- Cholinesterase-inhibitor therapy for dementia: novel clinical substrates and mechanisms for treatment response (Q44807722) (← links)
- Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka (Q45245185) (← links)
- Aging effects on the startle response and startle plasticity in Fischer F344 rats. (Q46037792) (← links)
- Alzheimer disease and other dementias (Q46363886) (← links)
- Neurochemistry of cognition: serotonergic and adrenergic mechanisms (Q46480742) (← links)
- GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats (Q48149835) (← links)
- Expression of p75(NTR), trkB and trkC in nonmanipulated and axotomized motoneurons of aged rats (Q48196774) (← links)
- Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment. (Q48229135) (← links)
- Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease (Q48311410) (← links)
- Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human Subjects (Q48662632) (← links)
- Collateral Sprouting of Central Noradrenergic Neurons during Aging: Histochemical and Neurochemical Studies in Intraocular Triple Transplants (Q48692025) (← links)
- Altered serotonin transporter sites in Alzheimerʼs disease raphe and hippocampus (Q53201403) (← links)